Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of cathepsin C: from pathophysiology to treatment
Brice Korkmaz, George H. Caughey, Iain Chapple, et al.
Pharmacology & Therapeutics (2018) Vol. 190, pp. 202-236
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation
Yansen Xiao, Min Cong, Jiatao Li, et al.
Cancer Cell (2021) Vol. 39, Iss. 3, pp. 423-437.e7
Open Access | Times Cited: 427
Tumor-associated neutrophils and neutrophil-targeted cancer therapies
Haiying Que, Qianmei Fu, Tianxia Lan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188762-188762
Open Access | Times Cited: 164
Dexamethasone mitigates sulfur mustard-induced stem cell deficiency in vivo in rabbit limbal tissue by reducing inflammation and oxidative stress
Rama Kant, Neha Mishra, Kushal Kandhari, et al.
Archives of Toxicology (2025)
Closed Access | Times Cited: 1
Zebrafish as a model for inflammation and drug discovery
Rodrigo Zanandrea, Carla Denise Bonan, Maria M. Campos
Drug Discovery Today (2020) Vol. 25, Iss. 12, pp. 2201-2211
Open Access | Times Cited: 67
Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
Brice Korkmaz, Adam Lesner, S. Marchand‐Adam, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13258-13265
Open Access | Times Cited: 59
Cathepsin V: Molecular characteristics and significance in health and disease
Fabien Lecaille, Thibault Chazeirat, Ahlame Saidi, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101086-101086
Open Access | Times Cited: 36
Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders
Yuka Nishibata, Suishin Arai, Mai Taniguchi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential
Michael C. McKelvey, Sinéad Weldon, Daniel F. McAuley, et al.
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 201, Iss. 2, pp. 141-147
Open Access | Times Cited: 53
Cathepsins: Potent regulators in carcinogenesis
Tejinder Pal Khaket, Taeg Kyu Kwon, Sun Chul Kang
Pharmacology & Therapeutics (2019) Vol. 198, pp. 1-19
Closed Access | Times Cited: 51
Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis
Michael L. Merchant, Michelle T. Barati, Dawn J. Caster, et al.
Journal of the American Society of Nephrology (2020) Vol. 31, Iss. 8, pp. 1883-1904
Open Access | Times Cited: 42
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy
Valeria De Pasquale, Anna Moles, Luigi Michele Pavone
Cells (2020) Vol. 9, Iss. 4, pp. 979-979
Open Access | Times Cited: 40
Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities
Xiao Bao Shen, Xing Chen, Zhao Yan Zhang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113818-113818
Closed Access | Times Cited: 37
Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
Seda Seren, Lohann Derian, Irem Keleş, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2003755-2003755
Open Access | Times Cited: 36
Tubular lysosomes harbor active ion gradients and poise macrophages for phagocytosis
Bhavyashree Suresh, Anand Saminathan, Kasturi Chakraborty, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 41
Open Access | Times Cited: 34
Cathepsin C inhibition as a potential treatment strategy in cancer
Brice Korkmaz, Anne‐Sophie Lamort, Roxane Domain, et al.
Biochemical Pharmacology (2021) Vol. 194, pp. 114803-114803
Open Access | Times Cited: 34
Cysteine cathepsins: A long and winding road towards clinics
Monika Biasizzo, Urban Javoršek, Eva Vidak, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101150-101150
Open Access | Times Cited: 24
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease
James D. Chalmers, Ralph Kettritz, Brice Korkmaz
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Cysteine cathepsins as therapeutic targets in inflammatory diseases
Matej Vizovišek, Eva Vidak, Urban Javoršek, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 6, pp. 573-588
Closed Access | Times Cited: 35
Targeting Cathepsin C in PR3-ANCA Vasculitis
Uwe Jerke, Claudia Eulenberg-Gustavus, Anthony Rousselle, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 5, pp. 936-947
Open Access | Times Cited: 22
The neutrophil: A key resourceful agent in immune‐mediated vasculitis
Karen Aymonnier, Jennifer Amsler, Peter Lamprecht, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 326-356
Open Access | Times Cited: 20
Cathepsin C in health and disease: from structural insights to therapeutic prospects
Chakriya Chitsamankhun, Nutwara Siritongtaworn, Benjamin Fournier, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Disarming the cavalry: targeting neutrophils to limit collateral damage in non-CF bronchiectasis
Omri A. Arbiv, Bradley S. Quon
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2401804-2401804
Closed Access
Protective effects of neutrophil serine protease inhibition against ischemia–reperfusion injury in lung or heart transplantation
Sevil Korkmaz‐Icöz, Gábor Szabó, Artur Giełdoń, et al.
FEBS Journal (2025)
Open Access
Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis
Shifen Wang, Tao Hong, Xingyun Zhao, et al.
Research Square (Research Square) (2025)
Closed Access
Downregulation of tropomyosin 2 promotes the progression of lung adenocarcinoma by regulating neutrophil infiltration through neutrophil elastase
Caixiu Huang, Hao Qiu, Changting Xu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top